General Archive
![](https://www.lifearc.org/wp-content/uploads/2024/01/image-1.png)
-
Articles & blogs
Bronchiectasis: an overlooked lung condition with untapped commercial and research potential
Bronchiectasis (BE) is a chronic lung condition that significantly impacts the lives of many people in the UK and around…
-
Bronchiectasis Industry Awareness Campaign
Bronchiectasis: a neglected and overlooked lung condition with unrealised commercial potential We are collaborating with industry experts and Asthma +Lung…
-
Accelerating CF Research
Accelerating CF Research: Strategies for rapidly progressing your science to clinical impact Join us at our industry symposium and unlock…
-
£3m fund for CF therapies
£3 million fund to accelerate development of new cystic fibrosis therapies LifeArc, as part of the CF AMR Syndicate, is…
-
Drug repurposing call to treat chronic respiratory infection
Drug repurposing call to treat chronic respiratory infection LifeArc has committed £10m to fund up to five consortia programmes that…
-
News releases
LifeArc’s Edinburgh labs featured in STV segment about innovations for people living with bronchiectasis
Recently, our team had the pleasure of hosting STV for an exciting feature at the BioQuarter campus in Edinburgh. Watch…
-
News releases
NHS trial uses artificial intelligence to predict severe infections and transform lives of people living with chronic lung conditions
A new NHS trial is using a home monitoring app combined with artificial intelligence (AI) to predict when people living…
-
News releases
LifeArc & Cystic Fibrosis Trust announce new £15m research funding to fast track treatment of lung infections
Focussing on innovative approaches to improve quality of life for people with cystic fibrosis (CF)
-
News releases
LifeArc plans two major funding calls to boost translational research in rare disease & lung health in cystic fibrosis
The calls are part of our wider £100m programme to support scientific innovation for people living with cystic fibrosis.
-
News releases
£3m fund to accelerate development of new CF therapies
Collaborative funding to drug discovery innovators to accelerate new treatments for people with cystic fibrosis.
-
News releases
LifeArc partners with EMBARC to improve healthcare for people living with bronchiectasis
Three-year partnership to improve healthcare for thousands of people across Europe living with bronchiectasis.
-
News releases
LifeArc announces £10m funding call for new chronic respiratory infection therapies
First major funding call announced as part of our £100m Chronic Respiratory Infection Translational Challenge